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Objective: In patients with a suspicion of prosthetic valve endocarditis
(PVE), detection of perivalvular infection can be difficult based only on
echocardiography, but has an important impact in guiding surgical indications.
The aim of this retrospective study was to test the interest of leukocyte scin-
tigraphy (LS) for detection of perivalvular infection in patients with suspicion
of non-complicated PVE.
Methods: LS was performed in 42 patients admitted for suspicion of PVE.
Results of LS were classified as positive, with either intense or mild accumulation
of radiolabeled leukocytes in the cardiac area, or negative. Macroscopical aspects
and bacteriology were obtained from patients who underwent cardiac surgery
(n=10). Clinical outcome was collected in patients treated medically (n=32).
Results: Among patients with an intense signal with LS who underwent
surgery (n=6), 5 had an abscess confirmed during intervention, and 1, post-
operatively. Patients with an intense accumulation of radiolabeled leukocytes
with scintigraphy and treated medically (n=3) had a poor outcome: death
(n=1) ; prosthetic valve dehiscence (n=1) ; recurrent endocarditis (n=1).
Among patients with a mild activity with LS (n=5), one patient developed a
large prosthetic valve dehiscence during follow-up. The 4 remaining patients
were treated medically and did not present any recurrent endocarditis after a
median follow-up of 14 months. No abscess was detected in patients with neg-
ative LS who underwent surgery (n=4). Among patients with negative LS
treated medically (n=24), none presented recurrent endocarditis after a mean
follow-up of 15±16 months. In total, LS helped to identify perivalvular infec-
tion or abscesses in 12 out of 42 patients (29%).
Conclusion: This retrospective study suggests that LS is useful for identi-
fication of perivalvular infection and could help in guiding surgical indications
in patients with suspicion of PVE.
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Background: Despite significant progress made in diagnostic and thera-
peutic modalities, infective endocarditis (IE) remains a serious affection asso-
ciated with considerable mortality and morbidity.
Aim: To describe the epidemiological and clinical aspects of native valve
infective endocarditis (IE) in a Tunisian high-volume tertiary care center and
to identify the predictors of outcome.
Methods and results: Demographic, clinical, laboratory, and echocardio-
graphic characteristics were examined in 176 patients who fulfilled the modi-
fied Duke criteria for native valve IE between January 1993 and December
2008. Logistic regression analysis was used to identify prognostic factors for
death. Mean age was 36.1±7.5 years. Diagnosis was definite in 85% of cases.
Median time to diagnosis was 19 days. Rheumatic heart disease (RHD) was
the predominant (47%) underlying heart condition. Mitral valve location was
the most frequent seat of IE (37.7%). One or more vegetations were detected
in more than 86.8% of cases. The median size of vegetation was >15 mm in
26% of cases. In 84 cases (48.5%), cultures remained negative. Serology was
positive in 16 cases, and in 4 cases leaflet culture identified the agent. Caus-
ative microorganisms were mainly Staphylococci (n=42 (24.2%), including
8 coagulase-negative Staphylococcus), and Streptococci (n=32). Overall mor-
tality was 18.6%. On multivariate analysis, congestive heart failure (hazard
ratio = 5.62, 95% CI 1.32 to 12.54, p=0.008) and large vegetations (>15 mm;
hazard ratio = 4.28, 95% CI 1.91 to 11.69, p=0.004) and neurological compli-
cations (hazard ratio = 3.27, 95% CI 1.84 to 9.11, p=0.002) were predictive of
in-hospital mortality.
Conclusion: IE remains a serious disease affecting a young population in
Tunisia, with RHD as still the most common underlying heart disease, and it
is associated with a high mortality.
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Background: Since the first description of infective endocarditis (IE), the
profile of the disease has evolved continuously with stable incidence.
Objective: To update information gained on the epidemiology profile of IE
in a Tunisian high-volume tertiary care center
Patients and methods: This was a descriptive retrospective study of patients
treated for IE from January 2001 to December 2010. The patients were divided in
two groups according to the date of diagnosis of IE : group 1 (from January 2001
to June 2006) and group 2 (from June 2006 to December 2011). These groups
were compared for epidemiologic factors and microbiological differences.
Results: A total of 297 patients admitted during the study period met the
modified Duke criteria for IE. The comparison of demographic and microbio-
logical characteristics of IE cases over time between the results of the two
groups showed that the annual incidence of IE was stable. The sex incidence
rates of IE, in particular, incidence among men was relatively stable across the
study period and ranged from 60% in 2001-2006 to 58% in 2006-2010, also
there was no significant increase in incidence among women (P=ns). Among
incident cases, there was a significant increasing age on presentation, with
median age increasing from 39.5 years in 2001-2006 to 51.5 years in 2006-
2010 (P=0.05). There were no statistically significant decreases in the propor-
tions of cases affecting the aortic valve (P=0.4) and in IE due to oral strepto-
cocci (P= ns) over time. Also there was no significant increase in the
incidence of Staphylococcus IE. However, the incidence of IE with negative
blood culture has remained stable and continues to be high, nearing 50%.
The rate of rheumatic heart disease as an underlying heart disease was
stable over time. However, the standardized incidence of IE has increased in
patients with prosthetic valves (P= ns). Overall in-hospital mortality rate
decreased from ((18.6% in 2001-2006 vs 14.6% in 2006-2010.
Conclusion: This study has shown that the annual incidence of IE is stable
in Tunisia. However, profound changes in the epidemiological profile of this
disease have not been noted in our population.
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Platypnea orthodeoxia syndrome (POS) is a rare condition with right to left
shunting through a Patent Foramen Ovale (PFO) that results in oxygen desa-
turation during postural changes. Few series are available on the functional
status after PFO closure. The aim of our study was to describe the impact of
PFO closure in this population.
Methods : We retrospectively included 24 consecutive patients with dyspnea
related to POS, aged 73.6±9.6 years old (min 52, max 86, 62.5% male) who were
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referred for PFO closure between Oct. 2006 and july 2011 in the Toulouse
Rangueil universitary hospital. Follow-up data were available in May 2012.
Results: At baseline, all patients had dyspnea (58.3% NYHA 4). Eight
patients (33.3%) had a history of stroke attack. POS was related to right pneu-
monectomy in 3 patients (12.5%), ascending aortic ectasy in 11 patients
(45.8%), hepato-renal polycystic disease in 2 patients (8.3%). Aneurysm of
the inter-atrial septum was observed in 12 patients (50%). PaO2 was lower
in erect position compared to recumbent position (50.4±6.8 versus
72.6±12.5 mmHg, p=0.0005). Closure of the PFO was performed percutane-
ously in 24 patients (100%). An additional surgical PFO closure was neces-
sary in 1 patient because of significant residual shunting. PaO2 in erect
position was significantly increased after closure (p=0.0254).
During follow-up, 4 patients (16.7%, p=0.125) had a complete relief of
their symptoms after closure. Dyspnea was significantly improved according
to NYHA functional class (p=0.023). General status improved in 75% patients
(p=0.025). Eight patients died (33.3%). Four deaths (50%) were related to
stroke attacks at respectively 18 days, 3,11 and 39 months after PFO closure.
Four deaths were not related to cardiac issue.
Conclusion: Patients referred for PFO closure for POS are old and at high
risk of mortality, particularly from stroke attacks. PFO closure is associated
with an improvement of the functional NYHA class and of the general status.
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Bleeding and femoral access complications which occurred after balloon
aortic valvuloplasty (BAV) may be enhanced by the systematic use of heparin
during the procedure. We assessed the hypothesis that BAV performed
without heparin may be associated with lower complications rates.
Methods: We conducted a retrospective analysis of all consecutive
patients who had undergone BAV in our center between 2008 and 2011. We
evaluated 3 groups: group 1 included patients whose BAV was performed
with large sheaths (10 to 12 F) and use of unfractionated heparin (UH)
(50IU/kg bolus IV); patients whose BAV was performed with use of smaller
size sheaths (8 or 9 F) who were divided into group 2 (with UH bolus) and
group 3 (without UH bolus). We collected all major in-hospital adverse
events, bleeding (≥BARC 3), vascular complications (including pseudoan-
erysm or arterio venous fistula) and acute limb ischemia.
Results: Overall, 132 patients were included in this study. The 3 groups
had similar median age (84 years) or previous lower extremity artery disease
(overall n= 36, 27%, p=0.79). Vascular and bleeding complications were
observed in 17 patients (12.8%) and were significantly higher when UH was
used (table 1) with a relative risk of 2.89 (1.18-6.1). Conversely, absence of
heparin did not increase ischemic complications or major in-hospital adverse
events (p=0.5). Vascular complications were similar among patients who
received heparin whatever the size of the used sheath (table 1).
Conclusion: Balloon aortic valvuloplasty performed without heparin
appears to be safe and is associated with a dramatic reduction of vascular and
bleeding events. Although randomization was not used, this marked difference
is difficult to explain by confounding factors.
Table 1 – Vascular and bleeding complications
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Background: Few data are currently available about patients characteris-
tics and procedural features associated with AKI after TAVI using the new
recommended VARC definition.
Methods: 99 patients underwent TAVI (1 procedural death, 78.8% trans-
femoral, 12.1% trans-apical/aortic and 9.1% subclavian access) between Feb-
ruary 2009 and September 2011 at Rennes university hospital. Creatinine level
was assessed daily at least up to 72 hours after TAVI. Patients’ characteristics,
procedural features and outcomes according to VARC definitions were studied
to evaluate determinants and prognostic impact of AKI.
Results: AKI occurred in 22 patients (22.2%). Among them, 5 were AKI
2 (5.1%), 8 were AKI 3 (9.1%) including 4 who needed dialysis (4%). At
baseline, compared to no AKI or AKI 1, AKI 2 or 3 patients had a higher
prevalence of moderate or severe chronic kidney disease (p=0.046) and ≥
grade 2 mitral regurgitation (p=0.03). During the post TAVI hospitalization,
AKI 2 or 3 was associated to a higher rate of death from any cause
(p=0.0009), major bleeding, acute heart failure (both p=0.002), infectious
complications (p=0.0008) and longer total and ICU hospitalization duration
(p=0.0004 and <0.0001 respectively). AKI 2 or 3 patients had a higher rate of
30-days and 6 months death from any cause (p=0.005 and p=0.0002 respec-
tively) but only because of the deaths occurring during the initial hospitaliza-
tion. Only AKI 3 was associated with a higher risk of 6-months NYHA class
III or IV (p=0.016).
Conclusion: AKI 2 or 3 as defined by the VARC criteria were associated
with a higher risk of post procedural death because of their association with
other major post procedural complications. AKI 3 was associated with a
higher risk of short term worse functional outcomes.
group 1 
(UH+, LS) 
n=23 
group 2 
(UH+, SS) 
n=46 
group 3
 (UH-, SS) 
n=63 
p
value
Femoral access and/or 
bleeding n=17 (12.8%) 
4 (17.3%) 9 (19.5.%) 4 (6.3%)* 0.007
Bleeding n=15 (11.3%) 4 (17.3%) 8 (17.3%) 3 (4.7%)* 0.004
Acute limb ischemia n=4 
(2.2%)
0 2 (4.3%) 2 (3.1%) 0.82
UH+: unfractionated heparin bolus 50 ui/kg; UH-: no heparin bolus; 
LS: large sheath; SS: small sheath
o AKI or AKI 1
= 85
AKI 2 or 3
=13
p value
Age-yr
Logistic EuroSCORE
79.0 ±10.2
19.8±12.2
80.5±6.7
19.3±10.2
0.63
0.89
Left ventricular ejection fraction-%
Aortic valve area-cm²
48.2±14.4
0.68±0.15
58.1±12.5
0.71±0.22
0.02
0.56
Figure 1: Time-to-event curv
